Management of Nocturnal Hot Flashes

First-Line Treatment Options

The National Comprehensive Cancer Network recommends gabapentin at a dose of 900 mg/day as the most effective medication for managing nocturnal hot flashes, reducing hot flash severity by up to 49% compared to placebo 1, 2
Gabapentin reduces hot flash severity by 46-49% at 8 weeks with 900 mg/day dosing, and is particularly useful for nocturnal hot flashes due to its sedative side effects 1, 3, 4
Venlafaxine reduces hot flash frequency and severity by 61% at 75 mg/day dosing, and is recommended as a first-line treatment option for patients without contraindications to any medication 5, 6, 7
The American College of Obstetricians and Gynecologists and the National Comprehensive Cancer Network suggest that venlafaxine has minimal effects on tamoxifen metabolism, making it safer than SSRIs for breast cancer patients on tamoxifen 5, 8

For patients without contraindications to any medication, the treatment algorithm recommends starting with gabapentin 900 mg at bedtime for nocturnal hot flashes, and considering switching to venlafaxine if there is an inadequate response after 4 weeks 1, 2, 4, 5, 7
For breast cancer patients on tamoxifen, gabapentin is the first choice, followed by venlafaxine, and paroxetine and fluoxetine should be avoided due to CYP2D6 inhibition 1, 2, 4, 7, 8

Estrogens and progestins are most effective for hot flashes, but are not recommended for women taking selective estrogen receptor modulators like tamoxifen, with a reduction in symptoms by 80-90% 5
Response to treatment should be evident within 4 weeks, and if no improvement is seen by then, the medication is unlikely to be effective 4

Gabapentin has a comparative efficacy of 46-49% reduction in hot flashes 1, 3
Venlafaxine has a comparative efficacy of 61% reduction at 75 mg/day 5, 7
Paroxetine has a comparative efficacy of 62-65% reduction at 12.5-25 mg/day 5, 3
Clonidine has a comparative efficacy of up to 46% reduction, but with more side effects 4